Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Moderna Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues135.1205.8108.4
            Revenue growth-34.4%89.9% 
Cost of goods sold0.00.00.0
Gross profit135.1205.8108.4
            Gross margin100.0%100.0%100.0%
Research and development454.1410.5274.7
General and administrative94.364.757.5
EBIT-413.3-269.4-223.8
            EBIT margin-306.0%-130.9%-206.4%
Pre-tax income-384.4-256.0-215.2
Income taxes0.3-0.11.0
            Tax rate 0.0% 
Net income-401.9-269.8-230.3
            Net margin-297.5%-131.1%-212.5%
 
Diluted EPS($4.95)($4.18)($3.79)
Shares outstanding (diluted)81.164.560.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy